microDAO
banner
microdao.bsky.social
microDAO
@microdao.bsky.social
5 followers 23 following 41 posts
🚀 Decentralizing the Fight Against AMR | 🌍 Community-driven funding for antimicrobials, vaccines & diagnostics | 🏛 Powered by transparent governance microDAO.bio
Posts Media Videos Starter Packs
Pinned
🌐 The future of science is changing.

DAOs: Decentralized Autonomous Organizations are global, community-powered networks.
👥 Members fund & govern projects collectively
📜 Decisions are transparent & on-chain
🌍 Borderless by design
Think of them as digital cooperatives for big challenges.

#Web3 #DAO
From hospitals to households, smarter use = stronger medicine. 💊

🔗 Read more: [https://www.visualcapitalist.com/top-35-countries-by-antibiotic-use-see-u-s-ranks/]
#AMR #MicroDAO #LetstalkAMR
Antibiotic use is rising fastest where access is easiest.
📈 Iran, South Africa, and Egypt lead global consumption; over 50 daily doses per 1,000 people, But misuse and over-prescription fuel antimicrobial resistance, a silent global crisis.👇
How can decentralized science fuel real AMR breakthroughs? 💡
In our latest post, we dive into what MicroDAO can learn from BioDAOs like VitaDAO, MicrobiomeDAO & SpineDAO, from funding models to community building, to token allocation challenges.👇
Learning from the Pioneers: What Other BioDAOs Teach Us About Building Sustainable Science
In our previous post, we explored why AMR Innovation needs new funding models rather than the traditional models of funding, and how Web3 can help unlock new ways to sustain antimicrobial resistance…
microdao.substack.com
Each represents a growing challenge in global health but where should MicroDAO focus first?
💭 Which of these do you think should be our top priority? The mic is yours 🎙️
Link: cdc.gov/mrsa/about

#AMR #GlobalHealth #MicroDAO #DeSci #InfectiousDiseases

🥩 Drug-resistant Nontyphoidal Salmonella
🍗 Salmonella serotype Typhi
💉 Drug-resistant Shigella
⚕️ Methicillin-resistant Staphylococcus aureus (MRSA)
🫁 Drug-resistant Streptococcus pneumoniae
🧫 Drug-resistant Tuberculosis (TB)
Let’s wrap up the week with a closer look at 11 pathogens the CDC classifies as Serious AMR Threats:

🦠 Drug-resistant Campylobacter
🧫 Drug-resistant Candida
💊 ESBL-producing Enterobacteriaceae
🧪 Vancomycin-resistant Enterococci (VRE)
🧬 Multidrug-resistant Pseudomonas aeruginosa
Reposted by microDAO
With a new enzyme for cell wall synthesis and an alternative cell division mechanism, mrsa has become highly resistant to antimicrobials

targetting these mechanisms can unlock new antimicrobials to tackle mrsa causes infections

sheffield.ac.uk/news/mrsas-d...

#letstalkaboutAMR

A resistant threat anywhere can easily become a threat at home, Global capacity is needed to slow development and prevent spread of antibiotic disease.
You have to get involved, and the time is now🚦 !
Source: cdc.gov/mrsa/about

#letstalkaboutAMR
Methicillin-resistant Staphylococcus aureus (MRSA) Basics
Protect yourself and your family from potentially serious MRSA infections.
cdc.gov
Antibiotic Resistance spreads easily across the globe 🌏, Resistant bacteria and fungi can spread across continent through people, animal and goods.
One billion people cross through international borders each year.👇
N. gonorrhoeae: 75% fluoroquinolone resistance globally
Link: iris.who.int/server/api/c...

#AMR #MicroDAO
The world’s antibiotics are losing power.

New data shows alarming AMR trends:
E. coli & K. pneumoniae: > 70% resistance in Africa
Acinetobacter spp.: 54.3% global carbapenem resistance
MRSA: 27% global > 50% in E. Mediterranean {👇}
Each of these poses a critical global risk — resistant, difficult to treat, and spreading fast. 🌍

Which of these do you think represents the most serious global threat today?
#AMR #DeSci #MicroDAO #GlobalHealth #AntimicrobialResistance
Here are the most urgent AMR threats right now:
🔹 Carbapenem-resistant Acinetobacter
🔹 Candida auris (C. auris)
🔹 Clostridioides difficile (C. difficile)
🔹 Carbapenem-resistant Enterobacteriaceae (CRE)
🔹 Drug-resistant Neisseria gonorrhoeae (N. gonorrhoeae)
🦠 Understanding AMR Threats: What’s the Most Urgent?
According to the CDC’s 2019 AMR Threat Report, 18 major pathogens are classified into three categories: Urgent, Serious, and Concerning threats.{Athread}👇
🧫 WHO IS AT RISK OF A.M.R?

The answer is Everyone.
Antimicrobial resistance doesn’t discriminate, it can affect anyone, at any stage of life.

Those receiving healthcare or living with weakened immune systems face higher risks but AMR also moves beyond hospitals;
MRSA contributed to >100,000 AMR-attributable deaths in 2019, This is why AMR is about more than hospitals, it’s about tracking resistance everywhere it can emerge.

🔍 At MicroDAO, we’re focused on building surveillance & research tools so we can measure
Methicillin-resistant Staphylococcus aureus (MRSA) Basics
Protect yourself and your family from potentially serious MRSA infections.
www.cdc.gov
🧬 Hello Micronauts! Did You Know?

Staphylococcus aureus (often just called “staph”) lives harmlessly in the nose or on the skin of 30% of people, but when it becomes methicillin-resistant (MRSA), it can resist multiple antibiotics making infections far harder to treat. #Athread
Antimicrobial resistance (AMR) doesn’t just happen in hospitals — it’s in our food, soil, and water. 🌍🧫
At MicroDAO, we’re working to build a system where data, collaboration, and decentralization help us track resistance everywhere it matters.
Happy New Week, Micronauts! 🌍💜
I hope we’re all starting the week strong.
This is a kind reminder to those who haven’t yet read our previous Substack post.
Your feedback and engagement are invaluable as we continue shaping the MicroDAO vision together.
🔗
Why AMR Innovation Needs New Funding Models, and How Web3 Can Help
In our earlier posts, we introduced MicroDAO’s vision: to build a new, decentralised infrastructure for tackling antimicrobial resistance (AMR), one of the most urgent and complex global health…
microdao.substack.com
💡 AMR is one of the most urgent health threats today; broken funding systems slow innovation.

MicroDAO is rethinking the model:
✅ Decentralised fundraising
✅ Transparent incentives
✅ Global participation

Science needs new infrastructure. 🌍🧠
🔗 [https://shorturl.at/n3L29]
Why AMR Innovation Needs New Funding Models, and How Web3 Can Help
In our earlier posts, we introduced MicroDAO’s vision: to build a new, decentralised infrastructure for tackling antimicrobial resistance (AMR), one of the most urgent and complex global health…
microdao.substack.com
Wishing you a Happy New Month from MicroDAO! 🌍✨ Our fight against antimicrobial resistance continues, transforming knowledge into action and challenges into opportunities. The road ahead is long, but our commitment is stronger
At MicroDAO, we’re building bottom-up solutions for AMR:
🔹 Community-powered sample collection
🔹 Open protocols across humans, animals, environment
🔹 Tools & dashboards for real-time insights

Join us 👉 [join.microdao.bio]
Join Working Group
join.microdao.bio